Sign up for free insights newsletter
A1

Aflac Incorporated

A1FL34SA

Need professional-grade analysis? Visit stockanalysis.com

R$613.20
+0.00%
End of day
Market Cap

$316.64B

P/E Ratio

58.17

Employees

12,694

Dividend Yield

147.00%

Price Chart

Risk-Adjusted Performance

Ratio1W1M3M6M1Y5YScore
Sortino0.801.63-0.070.71
Calmar1.752.39-0.041.22
Sharpe0.490.93-0.050.41
Omega1.462.171.001.51
Martin3.727.52-0.093.40
Ulcer1.871.275.163.04

Aflac Incorporated (A1FL34) Price Performance

Aflac Incorporated (A1FL34) trades on SA in BRL. The company is classified in the Financial Services sector under the Insurance - Life industry. The stock currently trades at BRL613.20.

Over the past year, A1FL34 has traded between a low of BRL552.82 and a high of BRL615.99. The stock has lost 0.5% over this period. It is currently 10.9% above its 52-week low.

Aflac Incorporated has a market capitalization of $316.64B, with a price-to-earnings ratio of 58.17 and a dividend yield of 147.00%.

About Aflac Incorporated

Aflac Incorporated, through its subsidiaries, provides supplemental health and life insurance products. The company operates in two segments, Aflac Japan and Aflac U.S. The Aflac Japan segment offers cancer, medical, nursing care, whole life, and GIFT insurance products, as well as WAYS and child endowment, and Tsumitasu insurance products in Japan. The Aflac U.S. segment provides accident, disability, cancer, critical illness, hospital indemnity, dental, vision, and life insurance products in the United States. The company sells its products through individual, independent corporate, and affiliated corporate agencies; banks; independent associates/career agents; and brokers. Aflac Incorporated was founded in 1955 and is based in Columbus, Georgia.

Company Info

Exchange
SA
Currency
BRL
Country
Brazil

Financial Metrics

Revenue (TTM)
$17.16B
EBITDA
$4.79B
Profit Margin
21.24%
EPS (TTM)
35.63
Book Value
296.95

Technical Indicators

52 Week High
R$650.63
52 Week Low
R$552.82
50 Day MA
R$601.11
200 Day MA
R$587.43
Beta
0.65

Valuation

Trailing P/E
17.21
Forward P/E
N/A
Price/Sales
18.45
Price/Book
2.06
Enterprise Value
$321.59B